Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GEN3017 |
Trade Name | |
Synonyms | GEN 3017|GEN-3017 |
Drug Descriptions |
GEN3017 is a bispecific antibody targeting CD3 and TNFRSF8, which potentially induces T-cell activation and subsequent cytotoxicity of TNFRSF8-expressing tumor cells (Blood (2022) 140 (Supplement 1): 3153–3154). |
DrugClasses | CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GEN3017 | GEN3017 | 0 | 1 |